Prosecution Insights
Last updated: April 19, 2026
Application No. 18/038,755

FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM

Non-Final OA §102§103§112
Filed
May 25, 2023
Examiner
MCCULLEY, MEGAN CASSANDRA
Art Unit
1767
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Resonac Corporation
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
3y 5m
To Grant
75%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allow Rate
424 granted / 727 resolved
-6.7% vs TC avg
Strong +17% interview lift
Without
With
+16.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
48 currently pending
Career history
775
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
53.7%
+13.7% vs TC avg
§102
13.5%
-26.5% vs TC avg
§112
24.6%
-15.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 727 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-14 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The parentheses around limitations in the claims render the claims indefinite and must be removed. It is unclear if the text within the parentheses is included in the claims and further limits the subject matter of the claims, or whether it is an aside to the claims and is not further limiting. For the purpose of further examination, it is taken that the text within the parentheses further limits the claims. Appropriate correction is required. Parentheses in reference characters, such as Formula (1), Formulae (2-1) to (2-4) are proper and do not need to be removed. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-6, 8, 9, 12, and 13 are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by Minami et al. (US 2020/0010619). Regarding claim 1: Minami et al. teaches the fluorine containing ether compound: PNG media_image1.png 206 964 media_image1.png Greyscale (para. 212), which reads on the claimed structure: PNG media_image2.png 299 964 media_image2.png Greyscale specifically, R3 is a divalent organic group containing at least one polar group and an alicyclic structure having 6 carbons and does not contain a perfluoropolyether chain, R2 and R4 are perfluoropolyether chains, R1 and R5 are terminal groups containing two polar groups, in which individual polar groups are bound to different carbon atoms and the carbon atoms to which the polar groups are bound are bound to each other via a linking group containing a carbon atom to which the polar groups are not bound. Regarding claims 2 and 3: Minami et al. teaches R3 has the structure of formula (2-1) (see annotated structure above) where Y is -O- and X is an alicyclic structure having 6 carbons. Regarding claim 4: Minami et al. teaches a saturated alicyclic structure for R3 (see annotated structure above). Regarding claim 5: Minami et al. teaches cyclohexane (see annotated structure above). Regarding claim 6: Minami et al. teaches the at least one polar group of R3 is a group containing a polar group of a hydroxyl group (see annotated structure above). Regarding claim 8: Minami et al. teaches the two polar groups in R1 and R5 are all hydroxyl groups (see annotated structure above). Regarding claim 9: Minami et al. teaches the structure of formula (9) where i is 1. Regarding claim 12: Minami et al. teaches the compound is a lubricant for a magnetic recording medium (para. 42). Regarding claim 13: Minami et al. teaches a magnetic recording medium having a magnetic layer, a protective layer, and a lubricating layer sequentially provided on a substrate where the lubricating layer contains the fluorine containing ether compound (para. 43). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 7, 10, and 14 are rejected under 35 U.S.C. 103 as being unpatentable over Minami et al. (US 2020/0010619) as applied to claims 1 and 13 set forth above. Regarding claim 7: Minami et al. teaches R2 and R4 have the structure of claimed formula (4), where the disclosed n is the claimed b and the disclosed m is the claimed c. Minami et al. discloses m is 2-5 and n is 2-5 (para. 213), which overlaps the claimed range. In the case where the claimed ranges overlap or lie inside ranges disclosed by the prior art, a prima facie case of obviousness exists (MPEP 2144.05 I). Before the effective filing date of the claimed invention a person having ordinary skill in the art would have found it obvious to have overlapping m and n values and would have been motivated to do so since Minami et al. teaches they are sufficient to achieve the disclosed invention. Regarding claim 10: Minami et al. teaches the number average molecular weight is 1,000 to 10,000 (claim 12), which overlaps the claimed range. In the case where the claimed ranges overlap or lie inside ranges disclosed by the prior art, a prima facie case of obviousness exists (MPEP 2144.05 I). Before the effective filing date of the claimed invention a person having ordinary skill in the art would have found it obvious to use the overlapping number average molecular weight of the compound of Minami et al. and would have been motivated to do so since Minami et al. teaches this is an acceptable molecular weight to achieve the disclosed invention. Regarding claim 14: Minami et al. teaches the average film thickness of the lubricating layer is 0.5-3 nm (para. 44) which overlaps the claimed range. In the case where the claimed ranges overlap or lie inside ranges disclosed by the prior art, a prima facie case of obviousness exists (MPEP 2144.05 I). Before the effective filing date of the claimed invention a person having ordinary skill in the art would have found it obvious to use the overlapping thickness of Minami et al. and would have been motivated to do so since Minami et al. teaches this is an acceptable thickness to achieve the disclosed invention. Allowable Subject Matter Claim 11 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Minami et al. is the closest prior art which teaches the structure show above. However, Minami et al. does not teach any of the specific structures claimed in claim 11. Further, there is no teaching or suggestion found in the prior art to replace one of the longer arm/polar moieties on the alicyclic group with a shorter chain polar moiety as in the structures of claim 11. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The references teach fluorine containing ether compounds. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to Megan McCulley whose telephone number is (571)270-3292. The examiner can normally be reached Monday - Friday 9-5:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MEGAN MCCULLEY/Primary Examiner, Art Unit 1767
Read full office action

Prosecution Timeline

May 25, 2023
Application Filed
Feb 27, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600814
Electric Insulation Material and/or Impregnation Resin for a Wrapping Tape Insulation for a Medium- and/or High-Voltage Machine
2y 5m to grant Granted Apr 14, 2026
Patent 12583965
POLYMERIZATIONS IN SUPERCRITICAL CARBON DIOXIDE, PRODUCTS OF SAME, AND USES THEREOF
2y 5m to grant Granted Mar 24, 2026
Patent 12577346
BENZOXAZINE COMPOUND-CONTAINING COMPOSITION, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF
2y 5m to grant Granted Mar 17, 2026
Patent 12540254
Epoxy Compositions and Methods of Use
2y 5m to grant Granted Feb 03, 2026
Patent 12540249
CATIONIC ELECTRODEPOSITION COATING COMPOSITION
2y 5m to grant Granted Feb 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
75%
With Interview (+16.6%)
3y 5m
Median Time to Grant
Low
PTA Risk
Based on 727 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month